Company news
Cheng Du Sheng Nuo Biotec Co., Ltd. news in 2025
Cheng Du Sheng Nuo Biotec Co., Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on Progress in Major Daily Operation Contracts of Wholly-owned Subsidiary
December 30, 2025
Announcement on Completing Term Change and Election of Board of Directors and Appointing Senior Management Members and Securities Affairs Representative
December 17, 2025
Announcement on Shareholding Reduction Results for Shareholders Holding Over 5% Shares, Partial Directors and Senior Management Members
December 14, 2025
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares to Below 5% and Reaching 1% Scale
December 10, 2025
Announcement on Voluntary Disclosure of Pentapeptide-18 Passing the New Cosmetic Ingredient Registration
December 3, 2025
Announcement on Election of Board of Directors at Expiry of Term of Office
December 1, 2025
Announcement on Shareholding Reduction Plan of Partial Directors and Senior Management Members
November 30, 2025
Announcement on Voluntary Disclosure of Notice on Listing Application Approval for Vepnadeptide Drug Substance
November 19, 2025
Announcement on Implementation of Interim Dividend Distribution for 2025
November 10, 2025
Announcement on Making Provisions for Asset Impairment for the First Three Quarters of 2025
October 27, 2025
Indicative Announcement on Shareholder Terminating Concerted Action Relationship and Equity Change Reaching 1% Scale
October 14, 2025
Announcement on Voluntary Disclosure of Earnings Preannouncement for the First Three Quarters of 2025
October 13, 2025
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
September 17, 2025
Announcement on Shareholding Reduction Plan for Shareholders Holding Over 5% Shares, Partial Directors and Senior Management Members
August 22, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
August 21, 2025
2025 Semi-annual Report
August 14, 2025
Announcement on Voluntary Disclosure of Obtaining Drug Registration Certificate for Ganirelix Injection
July 22, 2025
Announcement on Voluntary Disclosure of Obtaining Drug Registration Certificate for Exenatide Injection
June 30, 2025
Announcement on Voluntary Disclosure of 2025 Semi-annual Earnings Preannouncement
June 19, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 8, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 15, 2025
Report for Q1 2025
April 24, 2025
Announcement on Voluntary Disclosure of Earnings Preannouncement for Q1 2025
March 30, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025